Immunohematology Market Insights, 2017-2025

Immunohematology Market (Product - Analyzers (Automatic and Semi-automatic/Non-automatic), Reagents; Application - Blood Typing, Antibody Screening; End use - Hospitals, Academic and Research Institutes, Diagnostic and Reference Laboratories, Blood Banks) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 - 2025

Rising Prevalence of Hematological Disorders Fosters Growth in Immunohematology Market

Some of the most notable and prominent factors influencing the demand dynamics in the global immunohematology market include increasing awareness among the global population pertaining to the importance of blood donation as well as rising requirement for effective detection and diagnosis of blood related diseases. Various public as well as private entities, along with various non-governmental organizations or NGOs are organizing awareness campaigns to underscore the importance of blood donation. Several organizations are also promoting awareness regarding to the usage of safe blood and blood products. These trends are anticipated to work favorably for the enhancement of the global immunohematology market in coming years.

Rising prevalence of various hematological disorders i.e. diseases associated with blood as well as blood forming organs, is also expected to fuel the demand in the global immunohematology market in coming years. Some of the most notable types of hematological disorders are thalassemia, leukemia, sickle cell anemia, lymphoma, and hemophilia, among others. For example, as per the study by the World Health Organization in 2020, around 4,74,519 new cases of leukemia were reported in 2020. Furthermore, more than 3,11,594 deaths were caused by leukemia in 2020. This rise in the prevalence of leukemia is anticipated to drive the demand for effective treatment and testing solutions in the global immunohematology market within the next few years.

Moreover, rising healthcare infrastructure upgradation, increase in expenditure on research and development for advancing the diagnosis as well as treatment of various hematological diseases, and favorable government policies and initiatives are also expected to foster the development in the global immunohematology market in the next few years. Advancements in the global immunohematology market have paved way for automated hematological devices, high volume sample output, enhanced patient data management, software upgradation, and increase in the storage capacities. However, these technological advancements have also surged the costs of various devices and software tools in the global immunohematology market. The high cost associated with hematology equipment such as software and devices may hamper the growth in the global immunohematology market in coming years.

Global Immunohematology Market: Snapshot 

Rapid increase in the global disease burden and rise in the demand for blood- and plasma-derived products such as platelets, immunoglobulin, and plasma factors are augmenting the demand for immunohematology testing instruments and reagents. The number of patients with different hematological and other chronic diseases is also increasing rapidly across the world. This is likely to raise the number of surgical procedures in the near future, consequently propelling the demand for blood transfusions. Demand for advanced immunohematology tests in also anticipated to increase during the forecast period in order to maintain the quality standards and safety profiles during blood transfusions.

Awareness among the general public regarding the importance of blood compatibility and transfusion-related diseases is increasing due to the development of health care infrastructure, government campaigns, and increasing per capita income in developed as well as developing countries. Awareness among patients about proper compatibility tests for transfusion is also increasing. Increasing health care expenditure and rising worldwide concerns about medical safety are also driving the global immunohematology market. Moreover, government reimbursement programs in developed as well as developing countries are likely to provide growth opportunities to the immunohematology market in the near future. Demand–supply gap of safe and adequate human blood and plasma is a major bottleneck in the blood transfusion & blood typing industry. According to the World Health Organization, there is a significant difference between the blood demand–supply gap in developing countries and that in developed countries. Developed countries account for more than 50% of the global blood collections. These countries represent only 19% of the global population. Supply disorders in both source materials and finished products, if not managed properly, can hamper the global immunohematology market during the forecast period.

immunohematology-market.jpg

Advancements in the immunohematology technology have led to rapid development in the diagnostic approach toward in vitro study of the antigen–antibody interaction, facilitating improvement in the compatibility reaction between the donor’s blood and the recipient’s blood. Technological improvements in devices and reagents available for immunohematology testing have enabled clinicians to provide proper emergency assistance to patients. These technological advancements include development of automated systems which make the identification process easier and provide more accurate results as compared to manual systems.

Based on product, the global immunohematology market has been segmented into analyzers and reagents. The analyzers segment has been sub-segmented into automatic analyzers and semi-automatic/non-automatic analyzers. Based on application, the global immunohematology market has been divided into blood typing and antibody screening.  Based on end-user, the market has been classified into hospitals, academic & research institutes, diagnostic & reference laboratories, and blood banks. The hospitals segment is expected to remain dominant during the forecast period, due to increasing usage of automated analyzers with high throughput in hospitals.

Geographically, the global immunohematology market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2016 and is projected to continue its dominance between 2017 and 2025. Growth of the market in North America is primarily attributable to the increased funding by governments and the private sector and large volumes of blood transfusions. In addition, increased focus on research by pharmaceutical companies and well-established health care infrastructure are major factors driving the market in the region. The market in Europe is projected to expand at a significant CAGR from 2017 to 2025. Europe held the second-largest market share in 2016. High adoption and usage of superior-quality diagnostics and treatments is one of the major factors driving the market in the region. This can be attributed to increasing number of diagnostic laboratories and blood banks, rising government funding for research activities, and growing application of immunohematology in transfusion safety in the region. Asia Pacific is one of the rapidly developing regions in the world. High per capita income has increased the consumption of blood products in the region.

Key companies profiled in the report are Bio-Rad Laboratories, Inc., Grifols, S.A., Ortho Clinical Diagnostics, IMMUCOR, INC., Abbott Laboratories, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA, and Siemens Healthineers. These players are adopting organic and inorganic growth strategies to expand their product offerings, enhance their geographical reach, widen their customer base, and gain market share. In 2016, Grifols, S.A. won a contract for supplying blood-typing solutions to the Red Cross of South Korea. The Malaysian National Blood Bank renewed its contract for Grifols’s NAT technology that analyzes about 450,000 blood donations every year.

The global immunohematology market has been segmented as follows:

Product

  • Immunohematology Analyzers 
    • Automatic
    • Semi-automatic/Non-automatic
  • Immunohematology Reagents   

Application

  • Blood Typing
  • Antibody Screening

End-user

  • Hospitals
    • 500+ Beds
    • 200–499 Beds
    • Less Than 200 Beds
  • Academic & Research Institutes
  • Diagnostic & Reference Laboratories
  • Blood Banks

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Australia & New Zealand
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Frequently Asked Questions

What is the total market worth of immunohematology market?

Immunohematology market to reach value of US$ 1,991.8 Mn by 2025

What is the anticipated CAGR of the immunohematology market in the forecast period?

Immunohematology market is projected to expand at a CAGR of 3.5% from 2017 to 2025

What are the key driving factors for the growth of the immunohematology market?

Immunohematology market is driven by rising awareness among people in developed as well as developing countries and increasing health care expenditure and rising worldwide concerns about medical safety

Which region is expected to project the highest market share in the global immunohematology market?

North America is projected to be the largest share in the global immunohematology market during the forecast period

Who are the key players in the global immunohematology market?

Key players in the immunohematology market include Bio-Rad Laboratories, Inc., Grifols S.A., Ortho Clinical Diagnostics, IMMUCOR, INC., Abbott Laboratories, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc.

    Section 1 Preface
    1.1 Report Scope and Market Segmentation
    1.2 Research Highlights

    Section 2 Assumptions and Research Methodology
    2.1 Assumptions
    2.2 Research Methodology

    Section 3 Executive Summary
    3.1 Global Immunohematology Market Snapshot
    3.2 Market Share Analysis, by Region, 2016
    3.3 Market Opportunity Map

    Section 4 Market Overview
    4.1 Immunohematology Market Taxonomy
    4.2 Key Market Advancements
    4.3 Global Immunohematology Market Size (US$ Mn) Forecast, 2015–2025
    4.4 Global Immunohematology Market Outlook

    Section 5 Market Dynamics
    5.1 Drivers and Restraints Snapshot Analysis
    5.2 Drivers
    5.3 Restraints
    5.4 Opportunities
    5.5 Immunohematology Market: Porter’s Five Forces Analysis
    5.6 Key Success Factors of Top 3 Companies
    5.7 Estimated blood donations by WHO region , 2013
    5.8 Healthcare Sector Overview

    Section 6 Immunohematology Market Analysis, by Product
    6.1 Introduction
    6.2 Global Immunohematology Market Value Share Analysis, by Product
    6.3 Global Immunohematology Market Forecast, by Product
          6.3.1 Analyzers
                  6.3.1.1 Automatic
                  6.3.1.2 Semi-automatic/Non-automatic
          6.3.2 Reagents
    6.4 Market Attractiveness Analysis, by Product
    6.5 Key Trends

    Section 7 Immunohematology Market Analysis, by Application
    7.1 Introduction
    7.2 Global Immunohematology Market Value Share Analysis, by Application
    7.3 Global Immunohematology Market Forecast, by Application
          7.3.1 Blood Typing
          7.3.2 Antibody Screening
    7.4 Market Attractiveness Analysis, by Application
    7.5 Key Trends

    Section 8 Immunohematology Market Analysis, by End-user
    8.1 Introduction
    8.2 Global Immunohematology Market Value Share Analysis, by End-user
    8.3 Global Immunohematology Market Forecast, by End-user
          8.3.1 Hospitals
                  8.3.1.1 500+ Beds
                  8.3.1.2 200–499 Beds
                  8.3.1.3 Less Than 200 Beds
          8.3.2 Academic & Research Institutes
          8.3.3 Diagnostic & Reference Laboratories
          8.3.4 Blood Banks
    8.4 Market Attractiveness Analysis, by End-user

    Section 9 Immunohematology Market Analysis, by Region
    9.1 Global Immunohematology Market Scenario
    9.2 Global Immunohematology Market Value Share Analysis, by Region
    9.3 Global Immunohematology Market Forecast, by Region
    9.4 Market Attractiveness Analysis, by Region

    Section 10 North America Immunohematology Market Analysis
    10.1 Regional Outlook
    10.2 Market Overview
    10.3 Market Analysis, by Product
          10.3.1 Market Value Share Analysis, by Product
          10.3.2 Market Size (US$ Mn) Forecast, by Product
                  10.3.2.1 Analyzers
                             10.3.2.1.1 Automatic
                             10.3.2.1.2 Semi-automatic/Non-automatic
                  10.3.2.2 Reagents
    10.4 Market Analysis, by Application
          10.4.1 Market Value Share Analysis, by Application
          10.4.2 Market Size (US$ Mn) Forecast, by Application
                  10.4.2.1 Blood Typing
                  10.4.2.2 Antibody Screening
    10.5 Market Analysis, by End-user
          10.5.1 Market Value Share Analysis, by End-user
          10.5.2 Market Size (US$ Mn) Forecast, by End-user
                  10.5.2.1 Hospitals
                             10.5.2.1.1 500+ Beds
                             10.5.2.1.2 200–499 Beds
                             10.5.2.1.3 Less Than 200 Beds
                  10.5.2.2 Academic & Research Institutes
                  10.5.2.3 Diagnostic & Reference Laboratories
                  10.5.2.4 Blood Banks
    10.6 Market Analysis, by Country
          10.6.1 Market Value Share Analysis, by Country
          10.6.2. Market Size (US$ Mn) Forecast, by Country, 2017–2025
                  10.6.2.1 U.S.
                             10.6.2.1.1 U.S. Market Size (US$ Mn) Forecast, by Product
                             10.6.2.1.2 U.S. Market Size (US$ Mn) Forecast, by Application
                             10.6.2.1.3 U.S. Market Size (US$ Mn) Forecast, by End-user
                  10.6.2.2 Canada
    10.7 Market Attractiveness Analysis
          10.7.1 by Country
          10.7.2 by Product
          10.7.3 by Application
          10.7.4 by End-user

    Section 11 Europe Immunohematology Market Analysis
    11.1 Regional Outlook
    11.2 Market Overview
    11.3 Market Analysis, by Product
          11.3.1 Market Value Share Analysis, by Product
          11.3.2 Market Size (US$ Mn) Forecast, by Product
                  11.3.2.1 Analyzers
                             11.3.2.1.1 Automatic
                             11.3.2.1.2 Semi-automatic/Non-automatic
          11.3.2.2 Reagents
    11.4 Market Analysis, by Application
          11.4.1 Market Value Share Analysis, by Application
          11.4.2 Market Size (US$ Mn) Forecast, by Application
                  11.4.2.1 Blood Typing
                  11.4.2.2 Antibody Screening
    11.5 Market Analysis, by End-user
          11.5.1 Market Value Share Analysis, by End-user
          11.5.2 Market Size (US$ Mn) Forecast, by End-user
                  11.5.2.1 Hospitals
                             11.5.2.1.1 500+ Beds
                             11.5.2.1.2 200–499 Beds
                             11.5.2.1.3 Less Than 200 Beds
                  11.5.2.2 Academic & Research Institutes
                  11.5.2.3 Diagnostic & Reference Laboratories
                  11.5.2.4 Blood Banks
    11.6 Market Analysis, by Country/Sub-region
          11.6.1 Market Value Share Analysis, by Country/Sub-region
          11.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
                  11.6.2.1 U.K.
                  11.6.2.2 Germany
                  11.6.2.3 France
                  11.6.2.4 Spain
                  11.6.2.5 Italy
                  11.6.2.6 Rest of Europe
    11.7 Market Attractiveness Analysis
          11.7.1 by Country/Sub-region
          11.7.2 by Product
          11.7.3 by Application
          11.7.4 by End-user

    Section 12 Asia Pacific Immunohematology Market Analysis
    12.1 Regional Outlook
    12.2 Market Overview
    12.3 Market Analysis, by Product
          12.3.1 Market Value Share Analysis, by Product
          12.3.2 Market Size (US$ Mn) Forecast, by Product
                  12.3.2.1 Analyzers
                             12.3.2.1.1 Automatic
                             12.3.2.1.2 Semi-automatic/Non-automatic
          12.3.2.2 Reagents
    12.4 Market Analysis, by Application
          12.4.1 Market Value Share Analysis, by Application
          12.4.2 Market Size (US$ Mn) Forecast, by Application
                  12.4.2.1 Blood Typing
                  12.4.2.2 Antibody Screening
    12.5 Market Analysis, by End-user
          12.5.1 Market Value Share Analysis, by End-user
          12.5.2 Market Size (US$ Mn) Forecast, by End-user
                  12.5.2.1 Hospitals
                             12.5.2.1.1 500+ Beds
                             12.5.2.1.2 200–499 Beds
                             12.5.2.1.3 Less Than 200 Beds
                  12.5.2.2 Academic & Research Institutes
                  12.5.2.3 Diagnostic & Reference Laboratories
                  12.5.2.4 Blood Banks
    12.6 Market Analysis, by Country/Sub-region
          12.6.1 Market Value Share Analysis, by Country/Sub-region
          12.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
                  12.6.2.1 Australia & New Zealand
                  12.6.2.2 Japan
                  12.6.2.3 China
                  12.6.2.4 India
                  12.6.2.5 Rest of Asia Pacific
    12.7 Market Attractiveness Analysis
          12.7.1 by Country/Sub-region
          12.7.2 by Product
          12.7.3 by Application
          12.7.4 by End-user

    Section 13 Latin America Immunohematology Market Analysis
    13.1 Regional Outlook
    13.2 Market Overview
    13.3 Market Analysis, by Product
          13.3.1 Market Value Share Analysis, by Product
          13.3.2 Market Size (US$ Mn) Forecast, by Product
                  13.3.2.1 Analyzers
                             13.3.2.1.1 Automatic
                             13.3.2.1.2 Semi-automatic/Non-automatic
                  13.3.2.2 Reagents
    13.4 Market Analysis, by Application
          13.4.1 Market Value Share Analysis, by Application
          13.4.2 Market Size (US$ Mn) Forecast, by Application
                  13.4.2.1 Blood Typing
                  13.4.2.2 Antibody Screening
    13.5 Market Analysis, by End-user
          13.5.1 Market Value Share Analysis, by End-user
          13.5.2 Market Size (US$ Mn) Forecast, by End-user
                  13.5.2.1 Hospitals
                             13.5.2.1.1 500+ Beds
                             13.5.2.1.2 200–499 Beds
                             13.5.2.1.3 Less Than 200 Beds
                  13.5.2.2 Academic & Research Institutes
                  13.5.2.3 Diagnostic & Reference Laboratories
                  13.5.2.4 Blood Banks
    13.6 Market Analysis, by Country/Sub-region
          13.6.1 Market Value Share Analysis, by Country/Sub-region
          13.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
                  13.6.2.1 Brazil
                  13.6.2.2 Mexico
                  13.6.2.3 Rest of Latin America
    13.7 Market Attractiveness Analysis
          13.7.1 by Country/Sub-region
          13.7.2 by Product
          13.7.3 by Application
          13.7.4 by End-user

    Section 14 Middle East & Africa Immunohematology Market Analysis
    14.1 Regional Outlook
    14.2 Market Overview
    14.3 Market Analysis, by Product
          14.3.1 Market Value Share Analysis, by Product
          14.3.2 Market Size (US$ Mn) Forecast, by Product
                  14.3.2.1 Analyzers
                             14.3.2.1.1 Automatic
                             14.3.2.1.2 Semi-automatic/Non-automatic
                  14.3.2.2 Reagents
    14.4 Market Analysis, by Application
          14.4.1 Market Value Share Analysis, by Application
          14.4.2 Market Size (US$ Mn) Forecast, by Application
                  14.4.2.1 Blood Typing
                  14.4.2.2 Antibody Screening
    14.5 Market Analysis, by End-user
          14.5.1 Market Value Share Analysis, by End-user
          14.5.2 Market Size (US$ Mn) Forecast, by End-user
                  14.5.2.1 Hospitals
                             14.5.2.1.1 500+ Beds
                             14.5.2.1.2 200–499 Beds
                             14.5.2.1.3 Less Than 200 Beds
                  14.5.2.2 Academic & Research Institutes
                  14.5.2.3 Diagnostic & Reference Laboratories
                  14.5.2.4 Blood Banks
    14.6 Market Analysis, by Country/Sub-region
          14.6.1 Market Value Share Analysis, by Country/Sub-region
          14.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
                  14.6.2.1 South Africa
                  14.6.2.2 GCC
                  14.6.2.3 South Africa
                  14.6.2.4 Israel
                  14.6.2.5 Rest of Middle East & Africa
    14.7 Market Attractiveness Analysis
          14.7.1 by Country/Sub-region
          14.7.2 by Product
          14.7.3 by Application
          14.7.4 by End-user

    Section 15 Company Profiles
    15.1 Immunohematology Market Share Analysis, by Company (2016)
    15.2 Company Profiles
          15.2.1 Bio-Rad Laboratories, Inc.
                  15.2.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                  15.2.1.2 Financial Overview
                  15.2.1.3 Product Portfolio
                  15.2.1.4 SWOT Analysis
                  15.2.1.5 Strategic Overview
          15.2.2 Grifols, S.A.
                  15.2.2.1 Company Overview (HQ, Business Segments, Employee Strength)
                  15.2.2.2 Financial Overview
                  15.2.2.3 Product Portfolio
                  15.2.2.4 SWOT Analysis
                  15.2.2.5 Strategic Overview
          15.2.3 Ortho Clinical Diagnostics
                  15.2.3.1 Company Overview (HQ, Business Segments, Employee Strength)
                  15.2.3.2 Financial Overview
                  15.2.3.3 Product Portfolio
                  15.2.3.4 SWOT Analysis
                  15.2.3.5 Strategic Overview
          15.2.4 IMMUCOR, INC.
                  15.2.4.1 Company Overview (HQ, Business Segments, Employee Strength)
                  15.2.4.2 Financial Overview
                  15.2.4.3 Product Portfolio
                  15.2.4.4 SWOT Analysis
                  15.2.4.5 Strategic Overview
          15.2.5 Abbott Laboratories
                  15.2.5.1 Company Overview (HQ, Business Segments, Employee Strength)
                  15.2.5.2 Financial Overview
                  15.2.5.3 Product Portfolio
                  15.2.5.4 SWOT Analysis
                  15.2.5.5 Strategic Overview
          15.2.6 Beckman Coulter, Inc.
                  15.2.6.1 Company Overview (HQ, Business Segments, Employee Strength)
                  15.2.6.2 Financial Overview
                  15.2.6.3 Product Portfolio
                  15.2.6.4 SWOT Analysis
                  15.2.6.5 Strategic Overview
          15.2.7 Thermo Fisher Scientific, Inc.
                  15.2.7.1 Company Overview (HQ, Business Segments, Employee Strength)
                  15.2.7.2 Financial Overview
                  15.2.7.3 Product Portfolio
                  15.2.7.4 SWOT Analysis
                  15.2.7.5 Strategic Overview
          15.2.8 Becton, Dickinson and Company
                  15.2.8.1 Company Overview (HQ, Business Segments, Employee Strength)
                  15.2.8.2 Financial Overview
                  15.2.8.3 Product Portfolio
                  15.2.8.4 SWOT Analysis
                  15.2.8.5 Strategic Overview
          15.2.9 Merck KGaA
                  15.2.9.1 Company Overview (HQ, Business Segments, Employee Strength)
                  15.2.9.2 Financial Overview
                  15.2.9.3 Product Portfolio
                  15.2.9.4 SWOT Analysis
                  15.2.9.5 Strategic Overview
          15.2.10 Siemens Healthineers14.2.5 Merck & Co., Inc.
                  15.2.10.1 Company Overview (HQ, Business Segments, Employee Strength)
                  15.2.10.2 Financial Overview
                  15.2.10.3 Product Portfolio
                  15.2.10.4 SWOT Analysis
                  15.2.10.5 Strategic Overview

    List of Tables

    Table 01: Global Immunohematology Market Size (US$ Mn) Forecast, by Product, 2015–2025
    Table 02: Global Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
    Table 03: Global Immunohematology Market Size (US$ Mn) Forecast, by Application, 2015–2025
    Table 04: Global Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    Table 05: Global Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
    Table 06: Global Immunohematology Market Size (US$ Mn) Forecast, by Region, 2017–2025
    Table 07: North America Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
    Table 08: North America Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
    Table 09: North America Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
    Table 10: North America Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    Table 11: North America Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
    Table 12: North America Immunohematology Market Size (US$ Mn) Forecast, by Country, 2017–2025
    Table 13: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
    Table 14: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
    Table 15: U.S. Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    Table 16: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
    Table 17: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Hospitals (by Analyzers), 2015–2025
    Table 18: Europe Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
    Table 19: Europe Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
    Table 20: Europe Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
    Table 21: Europe Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    Table 22: Europe Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
    Table 23: Europe Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
    Table 24: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
    Table 25: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
    Table 26: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
    Table 27: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    Table 28: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
    Table 29: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
    Table 30: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
    Table 31: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Analyzer, 2015–2025
    Table 32: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Application, 2015–2025
    Table 33: Latin America Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    Table 34: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
    Table 36: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
    Table 37: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
    Table 38: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
    Table 39: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Application, 2015–2025
    Table 40: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    Table 41: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
    Table 42: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025

    List of Figures

    Figure 01: Global Immunohematology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
    Figure 02: Market Value Share, by Product (2016)
    Figure 03: Market Value Share, by Application (2016)
    Figure 04: Market Value Share, by Region (2016)
    Figure 05: Global Immunohematology Market Value Share Analysis, by Product, 2016 and 2025
    Figure 06: Global Immunohematology Market Value Share Analysis, by Analyzers, 2016 and 2025
    Figure 07: Global Immunohematology Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzers, 2015–2025
    Figure 08: Global Immunohematology Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents, 2015–2025
    Figure 09: Global Immunohematology Market Attractiveness Analysis, by Product
    Figure 10: Global Immunohematology Market Value Share, by Application, 2016 and 2025
    Figure 11: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Blood Typing, 2015–2025
    Figure 12: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Antibody Screening, 2015–2025
    Figure 13: Global Immunohematology Market Attractiveness, by Application
    Figure 14: Global Immunohematology Market Value Share, by End-user, 2016 and 2025
    Figure 15: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2015–2025
    Figure 16: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Academic & Research Institutes, 2015–2025
    Figure 17: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diagnostic & Reference Laboratories, 2015–2025
    Figure 18: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Blood Banks, 2015–2025
    Figure 19: Global Immunohematology Market Attractiveness, by End-user
    Figure 20: Global Immunohematology Market Value Share, by Region, 2016 and 2025
    Figure 21: Global Immunohematology Market Attractiveness, by Region
    Figure 22: North America Immunohematology Market Size (US$ Mn) Forecast, 2017–2025
    Figure 23: North America Market Attractiveness Analysis, by Country
    Figure 24: North America Immunohematology Market Value Share Analysis, by Product, 2016 and 2025
    Figure 25: North America Immunohematology Market Value Share Analysis, by Application, 2016 and 2025
    Figure 26: North America Immunohematology Market Value Share Analysis, by End-user, 2016 and 2024
    Figure 27: North America Immunohematology Market Value Share Analysis, by Country, 2016 and 2025
    Figure 28: North America Immunohematology Market Attractiveness Analysis, by Product
    Figure 29: North America Immunohematology Market Attractiveness Analysis, by Application
    Figure 30: North America Immunohematology Market Attractiveness Analysis, by End-user
    Figure 31: Europe Immunohematology Market Size (US$ Mn) Forecast, 2017–2025
    Figure 32: Europe Immunohematology Market Attractiveness, by Country/Sub-region
    Figure 33: Europe Immunohematology Market Value Share, by Product, 2016 and 2025
    Figure 34: Europe Immunohematology Market Value Share, by Application, 2016 and 2025
    Figure 35: Europe Immunohematology Market Value Share, by End-user, 2016 and 2025
    Figure 36: Europe Immunohematology Market Value Share, by Country/Sub-region, 2016 and 2025
    Figure 37: Europe Immunohematology Market Attractiveness, by Product
    Figure 38: Europe Immunohematology Market Attractiveness, by Application
    Figure 39: Europe Immunohematology Market Attractiveness,  by End-user
    Figure 40: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
    Figure 41: Asia Pacific Immunohematology Market Attractiveness, by Country/Sub-region, 2017–2025
    Figure 42: Asia Pacific Immunohematology Market Value Share, by Product, 2016 and 2025
    Figure 43: Asia Pacific Immunohematology Market Value Share, by Application, 2016 and 2025
    Figure 44: Asia Pacific Immunohematology Market Value Share, by End-user, 2016 and 2025
    Figure 45: Asia Pacific Immunohematology Market Value Share, by Country/Sub-region, 2016 and 2025
    Figure 46: Asia Pacific Immunohematology Market Attractiveness, by Product
    Figure 47: Asia Pacific Immunohematology Market Attractiveness, by Application
    Figure 48: Asia Pacific Immunohematology Market Attractiveness, by End-user
    Figure 49: Latin America Immunohematology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
    Figure 50: Latin America Immunohematology Market Attractiveness Analysis, by Country/Sub-region, 2017-25
    Figure 51: Latin America Immunohematology Market Value Share Analysis, by Product, 2016 and 2025
    Figure 52: Latin America Immunohematology Market Value Share Analysis, by Application, 2016 and 2025
    Figure 53: Latin America Immunohematology Market Value Share Analysis by End-user, 2016 and 2024
    Figure 54: Latin America Immunohematology Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
    Figure 55: Latin America Immunohematology Market Attractiveness Analysis, by Product
    Figure 56: Latin America Immunohematology Market Attractiveness Analysis, by Application
    Figure 57: Latin America Immunohematology Market Attractiveness Analysis, by End-user
    Figure 58: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, 2015–2025
    Figure 59: Middle East & Africa Immunohematology Market Attractiveness, by Country/Sub-region
    Figure 60: Middle East & Africa Immunohematology Market Value Share, by Product, 2016 and 2025
    Figure 61: Middle East & Africa Immunohematology Market Value Share, by Application, 2016 and 2025
    Figure 62: Middle East & Africa Immunohematology Market Value Share, by End-user, 2016 and 2024
    Figure 63: Middle East & Africa Immunohematology Market Value Share, by Country/Sub-region, 2016 and 2025
    Figure 64: Middle East & Africa Immunohematology Market Attractiveness, by Product
    Figure 65: Middle East & Africa Immunohematology Market Attractiveness, by Application
    Figure 66: Middle East & Africa Immunohematology Market Attractiveness, by End-user
    Figure 67: Market Share of Prominent Key Players: Immunohematology Market, 2016

Copyright © Transparency Market Research, Inc. All Rights reserved